FIELD: medicine, phthisiology. SUBSTANCE: method involves prescription of ferrous sulfate oxide in therapeutic doses for some, at least, two days followed by its dosing with isonicotinic acid hydrazide preparation up to the end of treatment. Dose of ferrous sulfate oxide is at least by two- fold greater of the dose of isonicotinic acid hydrazide. Invention allows carrying out effective limitation of complications and adverse symptoms in treatment of tuberculosis and can be used for limitation of complications and adverse effects in treatment of tuberculosis. EFFECT: enhanced effectiveness of treatment. 2 cl, 2 tbl
展开▼